APA (7th ed.) Citation

Fang, W., Chen, Y., Nie, M., Zhou, X., Liu, Y., Tao, H., . . . Wang, X. (2025). Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation. Marine Drugs, 23(5), 214. https://doi.org/10.3390/md23050214

Chicago Style (17th ed.) Citation

Fang, Wenxuan, Ying Chen, Mingyi Nie, Xuefeng Zhou, Yonghong Liu, Huaming Tao, Bin Yang, and Xueni Wang. "Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation." Marine Drugs 23, no. 5 (2025): 214. https://doi.org/10.3390/md23050214.

MLA (9th ed.) Citation

Fang, Wenxuan, et al. "Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation." Marine Drugs, vol. 23, no. 5, 2025, p. 214, https://doi.org/10.3390/md23050214.